Disease-A-Month
Volume 53, Issue 1 , Pages 59-63 , January 2007

New Drugs and Vaccines

References 

  1. No author listed. The Global Plan to Stop TB. 2006-2015 (press announcement, January 27, 2006. Davos, Switzerland). Available at: www.who.int/tb/features_archive/global_plan_to_stop_tb/en/.
  2. Raviglione MC. Reichman and Hershfield’s Tuberculosis, A Comprehensive, International Approach. 3rd ed.. New York/London: Informa Healthcare; 2006;
  3. Ginsberg A, Spigelman M. New drugs for tuberculosis. In:  Raviglione MC editors. Reichman and Hershfield’s Tuberculosis, A Comprehensive International Approach. 3rd ed.. New York/London: Informa Healthcare; 2006;p. 1135–1151
  4. ATS/CDCP/IDSA. Treatment of tuberculosis. Am J Respir Crit Care Med. 2003;67:603–662
  5. Blumberg HM, Leonard MK, Jasmer RM. Update on the treatment of tuberculosis and latent tuberculosis infection. JAMA. 2005;293:2776–2784
  6. No author listed. Antibiotic gatifloxacin (Tequin) removed from market. http://www.mayoclinic.con/health/tequin/D100058.
  7. Gosling RD, Uiso LO, Sam NE, et al. The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis. Am J Respir Crit Care Med. 2003;168:1342–1345
  8. CDC. A strategic plan for the elimination of tuberculosis in the Unites States. MMWR Morb Mortal Wkly Rep. 1989;38(suppl 3):1–25
  9. Griffin R, Young D. The future of tuberculosis vaccinology. In:  Raviglione MC editors. Reichman and Hershfield’s Tuberculosis, A Comprehensive International Approach. 3rd ed.. New York/London: Informa Healthcare; 2006;p. 1153–1168
  10. Doherty TM, Rook G. Progress and hindrances in tuberculosis vaccine development. Lancet. 2006;367:947–949
  11. Orme IM. Preclinical testing of new vaccines for tuberculosis (A comprehensive review). Vaccine. 2006;24:2–19
  12. Aronson NE, Santosham M, Comstock GW, et al. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study. JAMA. 2004;291:2086–2091
  13. Martin C. Tuberculosis vaccines: past present and future. Curr Opin Pulm Med. 2006;112:186–191
  14. McShane H, Pathan AA, Sander CR, et al. Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials. Tuberculosis. 2005;85:47–52
  15. Horwitz MA. Recombinant BCG expressing Mycobacterium tuberculosis major extracellular proteins. Microbes Infect. 2005;7:947–954

 The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy, Department of Defense, or the United States Government.

PII: S0011-5029(06)00110-6

doi: 10.1016/j.disamonth.2006.10.008

Disease-A-Month
Volume 53, Issue 1 , Pages 59-63 , January 2007

Article Tools